These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1144 related articles for article (PubMed ID: 23898)

  • 21. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine.
    Cohen MH
    J Pharmacol Exp Ther; 1975 Sep; 194(3):475-9. PubMed ID: 240017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Compounds with presumable antitumor activity. III. 1-Substituted N,N'-di-2-pyrimidinyl (or pyrazinyl)methylenediamine].
    Chimirri A; Grasso S; Monforte P; Fenech G
    Farmaco Sci; 1984 Sep; 39(9):797-805. PubMed ID: 6500046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.
    Lippman MM; Laster WR; Abbott BJ; Venditti J; Baratta M
    Cancer Res; 1975 Apr; 35(4):939-45. PubMed ID: 1116151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of 1,2-bis diazoacetyl ethane.
    Emanuel NM; Konovalova NP; Djachkovskaya RF
    Cancer Treat Rep; 1976 Nov; 60(11):1601-4. PubMed ID: 191190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of antitumor polysaccharide fractions from Yucca glauca Nutt. (Lilliaceae).
    Ali MS; Sharma GC; Asplund RO; Nevins MP; Garb S
    Growth; 1978 Jun; 42(2):213-23. PubMed ID: 98392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z; Lukowicz J; Konopa J
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of a human tumor colony-forming assay to new drug screening.
    Shoemaker RH; Wolpert-DeFilippes MK; Kern DH; Lieber MM; Makuch RW; Melnick NR; Miller WT; Salmon SE; Simon RM; Venditti JM
    Cancer Res; 1985 May; 45(5):2145-53. PubMed ID: 3986767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors.
    Furusawa S; Mian AM
    Cancer Treat Rep; 1987 May; 71(5):441-6. PubMed ID: 3567967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of 2-chloroethyl (methylsulfonyl)methanesulfonate (clomesone, NSC 33847) against selected tumor systems in mice.
    Dykes DJ; Waud WR; Harrison SD; Laster WR; Griswold DP; Shealy YF; Montgomery JA
    Cancer Res; 1989 Mar; 49(5):1182-6. PubMed ID: 2537144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase.
    Johnson RK; Inouye T; Goldin A; Stark GR
    Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological activity of 1,4-dihydropyridine derivatives.
    Fiszer-Maliszewska L; Wieczorek J; Mordarski M; Balicki R; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):345-52. PubMed ID: 4084011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
    Khan AH; Driscoll JS
    J Med Chem; 1976 Feb; 19(2):313-7. PubMed ID: 1249812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential central nervous system antitumor agents. Hydantoin derivatives.
    Peng GW; Marquez VE; Driscoll JS
    J Med Chem; 1975 Aug; 18(8):846-9. PubMed ID: 1159704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential CNS antitumor agents--phenothiazines I: Nitrogen mustard derivatives.
    Hirata T; Driscoll JS
    J Pharm Sci; 1976 Nov; 65(11):1699-701. PubMed ID: 994007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
    Farquhar D; Benvenuto J
    J Med Chem; 1984 Dec; 27(12):1723-7. PubMed ID: 6502603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.